$CNNN
ConneXionONE Corp.

2023 Q4 Form 10-Q Financial Statement

#000168316823008103 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $628.0K $38.66K
YoY Change 1524.54%
Operating Profit -$628.0K -$38.66K
YoY Change 1524.54%
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income -$628.0K -$38.66K
YoY Change 1524.54%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$628.0K -$38.66K
YoY Change 1524.54%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 $0.00
Diluted Earnings Per Share -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 71.85M shares 71.85M shares 71.85B shares
Diluted Shares Outstanding 71.85M shares 71.85B shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $725.00 $834.00 $92.20K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables $442.0K $442.0K $238.0K
Total Short-Term Assets $442.7K $442.8K $330.2K
YoY Change 14.98% 34.11%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $442.7K $442.8K $330.2K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $442.7K $442.8K $330.2K
YoY Change 14.98% 34.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.141M $879.1K $663.8K
YoY Change 53.69% 32.43%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities $1.003M $1.003M
YoY Change 0.0%
Total Long-Term Liabilities $1.003M $1.003M
YoY Change 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.141M $879.1K $663.8K
Total Long-Term Liabilities $1.003M $1.003M
Total Liabilities $2.143M $1.882M $1.666M
YoY Change 22.84% 12.92%
SHAREHOLDERS EQUITY
Retained Earnings -$75.29M -$74.61M -$73.91M
YoY Change 1.84% 0.95%
Common Stock $76.57K $73.05K $72.57M
YoY Change -99.89% -99.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.701M -$1.439M -$1.336M
YoY Change
Total Liabilities & Shareholders Equity $442.7K $442.8K $330.2K
YoY Change 14.98% 34.11%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$628.0K -$38.66K
YoY Change 1524.54%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001182731
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-50075
dei Entity Registrant Name
EntityRegistrantName
CONNEXIONONE CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NC
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
30-1252905
dei Entity Address Address Line1
EntityAddressAddressLine1
530 Lytton Ave 2nd Floor #2061
dei Entity Address City Or Town
EntityAddressCityOrTown
Palo Alto
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94301
dei City Area Code
CityAreaCode
408
dei Local Phone Number
LocalPhoneNumber
533-8155
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
71850644 shares
CY2023Q3 us-gaap Cash
Cash
834 usd
CY2022Q4 us-gaap Cash
Cash
5032 usd
CY2023Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
442000 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
380000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
442834 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
385032 usd
CY2023Q3 us-gaap Assets
Assets
442834 usd
CY2022Q4 us-gaap Assets
Assets
385032 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
42500 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
88250 usd
CY2023Q3 AFTC Due To Related Party
DueToRelatedParty
836569 usd
CY2022Q4 AFTC Due To Related Party
DueToRelatedParty
654068 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
879069 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
742318 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2023Q3 us-gaap Liabilities
Liabilities
1881708 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1744957 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73050644 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73050644 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71850644 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71850644 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
73051 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
71851 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
73098135 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
72499335 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-74610060 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73931111 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1438874 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1359925 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
442834 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
385032 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
21246 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
28750 usd
us-gaap Professional Fees
ProfessionalFees
50787 usd
us-gaap Professional Fees
ProfessionalFees
58750 usd
CY2023Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
600000 usd
CY2022Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
600000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 usd
CY2023Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
6720 usd
CY2022Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
9905 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
28162 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
10064 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
627966 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
38655 usd
us-gaap Operating Expenses
OperatingExpenses
678949 usd
us-gaap Operating Expenses
OperatingExpenses
68814 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-627966 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-38655 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-678949 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-68814 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-627966 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38655 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-678949 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-68814 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-627966 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-38655 usd
us-gaap Net Income Loss
NetIncomeLoss
-678949 usd
us-gaap Net Income Loss
NetIncomeLoss
-68814 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.009
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.009
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.001
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.001
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.009
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.009
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.001
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.001
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71850644 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71850644 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72846644 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72846644 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71850644 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71850644 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72183640 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72183640 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1267435 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-30120 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1297555 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-39 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1297594 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-38655 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1336249 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1359925 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-34327 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1394252 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-16656 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1410908 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
600000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-627966 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1438874 usd
us-gaap Net Income Loss
NetIncomeLoss
-678949 usd
us-gaap Net Income Loss
NetIncomeLoss
-68814 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
600000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 usd
us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
-70000 usd
us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
-0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-45750 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8750 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-54699 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60064 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
132000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
237900 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-132000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-237900 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
182501 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
390159 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
182501 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
390159 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4198 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
92195 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5032 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
834 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92195 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84D_eus-gaap--UseOfEstimates_zFfRg98nxPB7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Use of estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s significant estimates include income taxes provision and valuation allowance of deferred tax assets; the fair value of financial instruments; the carrying value and recoverability of long-lived assets, including the values assigned to an estimated useful lives of computer equipment; and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management regularly reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2023Q3 AFTC Accrual Carryover From Prior Abandoned Operations
AccrualCarryoverFromPriorAbandonedOperations
336904 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-74610060 usd
CY2023Q3 AFTC Liabilities Carryover From Prior Abandoned Operations
LiabilitiesCarryoverFromPriorAbandonedOperations
665735 usd
CY2022Q4 AFTC Liabilities Carryover From Prior Abandoned Operations
LiabilitiesCarryoverFromPriorAbandonedOperations
665735 usd
CY2022Q4 AFTC Accrual Carryover From Prior Abandoned Operations
AccrualCarryoverFromPriorAbandonedOperations
336904 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73050644 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73050644 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71850644 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71850644 shares
CY2023Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1200000 shares
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
reverse stock split of a one-for-one thousand (1:1,000)
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
600000 usd
CY2023Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
74610060 usd

Files In Submission

Name View Source Status
0001683168-23-008103-index-headers.html Edgar Link pending
0001683168-23-008103-index.html Edgar Link pending
0001683168-23-008103.txt Edgar Link pending
0001683168-23-008103-xbrl.zip Edgar Link pending
aftc-20230930.xsd Edgar Link pending
connexion_ex3101.htm Edgar Link pending
connexion_ex3102.htm Edgar Link pending
connexion_ex3201.htm Edgar Link pending
connexion_ex3202.htm Edgar Link pending
connexion_i10q-093023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
connexion_i10q-093023_htm.xml Edgar Link completed
aftc-20230930_cal.xml Edgar Link unprocessable
aftc-20230930_lab.xml Edgar Link unprocessable
aftc-20230930_def.xml Edgar Link unprocessable
aftc-20230930_pre.xml Edgar Link unprocessable